Stock Based Compensation (Tables)

9 Months Ended

Jun. 30, 2018

Schedule Of Stock Compensation Expense [Table Text Block]

Stock compensation expense for the three and nine months ended June 30, 2018 and 2017 is as follows:

	Three Months Ended		Three Months Ended
	June 30, 2018		June 30, 2017
Stock Grants	$	78,000	$	60,000
Restricted Stock Grants		14,000		13,000
Option Grants		-		12,000
Employee Stock Purchase Plan		1,000		1,000
Subsidiary Option Grants		27,000		30,000
Total	$	120,000	$	116,000

	Nine Months Ended		Nine Months Ended
	June 30, 2018		June 30, 2017
Stock Grants	$	209,000	$	183,000
Restricted Stock Grants		40,000		39,000
Option Grants		17,000		37,000
Employee Stock Purchase Plan		2,000		2,000
Subsidiary Option Grants		83,000		82,000
Total	$	351,000	$	343,000

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the nine months ended June 30, 2018 is presented below:

Restricted Stock Activity for the Nine Months ended ‎June 30, 2018	Shares			Weighted-Average ‎Grant-Date Fair Value
Nonvested at September 30, 2017		70,000		$	1.73
Granted		20,000			1.37
Vested		(30,000	)		1.73
Cancelled		-			-
Nonvested and expected to vest at June 30, 2018		60,000		$	1.61

Stock Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

During the nine months ended June 30, 2018, no Dynasil stock options were granted. A summary of stock option activity for the nine months ended June 30, 2018 is presented below:

	Options Outstanding			Weighted Average ‎Exercise Price per ‎Share		Weighted Average Remain Contractual Term (in Years)
Balance at September 30, 2017		196,769		$	1.98		1.64
Outstanding and exercisable at September 30, 2017		196,769		$	1.98		1.64
Granted		-			-
Exercised		-			-
Cancelled		(36,232	)		1.82
Balance at June 30, 2018		160,537		$	2.01		1.18
Outstanding and exercisable at June 30, 2018		160,537		$	2.01		1.18

Subsidiary Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

During the three months ended June 30, 2018, no Xcede stock options were granted. A summary of Xcede stock option activity for the nine months ended June 30, 2018 is presented below:

	Options Outstanding			Weighted Average Exercise Price per Share		Weighted Average Remain Contractual Term (in Years)
Balance at September 30, 2016		123,147		$	2.30		1.69
Outstanding and exercisable at September 30, 2016		123,147		$	2.30		1.69
Granted		95,602			1.80		2.59
Exercised		-			-
Cancelled		(21,980	)		3.03
Balance at June 30, 2017		196,769		$	1.98		1.89
Outstanding and exercisable at June 30, 2017		196,769		$	1.98		1.89